<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01654627</url>
  </required_header>
  <id_info>
    <org_study_id>RGD001</org_study_id>
    <nct_id>NCT01654627</nct_id>
  </id_info>
  <brief_title>Guided Bone Regeneration Using Synthetic Membrane</brief_title>
  <official_title>Horizontal Guided Bone Regeneration for Dental Implants Using Synthetic Membrane (Regenecures' AMCA GBR Dental Membrane) a Prospective, Randomized,Controlled Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>RegeneCure, Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>RegeneCure, Ltd.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to examine the safety and usefulness of the Regenecure guided
      bone regeneration membrane for stimulating bone growth in patients that don't have enough
      bone for dental implant placement. The study will include 16 patients in each group, 20
      non-smokers and 12 smokers, a total of 32 patients will participate in the study.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>April 2013</start_date>
  <completion_date type="Anticipated">June 2015</completion_date>
  <primary_completion_date type="Anticipated">April 2015</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Bone volume</measure>
    <time_frame>Change from Baseline in bone volume at 6 months</time_frame>
    <description>Clinical effect on bone volume measured using CBCT. The volume of the newly formed bone will be evaluated by &quot;subtraction&quot; of the 2 cone beam CTs using digital measurements.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Histomorphometry</measure>
    <time_frame>6 months</time_frame>
    <description>Specimens will be prepared for histological staining (H&amp;E and Masson's trichrome stain). The stained samples will be evaluated for new bone, residual bone graft, marrow spaces and vascularity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety will be demonstrated by using VAS scale for pain measurements and if the PI will consider that any adverse event device related isn't clinically significant</measure>
    <time_frame>six months</time_frame>
    <description>Safety will be demonstrated by using VAS scale for pain measurements and if the PI will consider that any adverse event device related isn't clinically significant</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">32</enrollment>
  <condition>Jaw, Edentulous</condition>
  <condition>Jaw, Edentulous, Partially</condition>
  <arm_group>
    <arm_group_label>Regenecure AMCA GBR Dental membrane</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>16 patients will undergo the guided bone regeneration procedure using the Regenecure AMCA Membrane</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Collagen membrane</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>16 patients will undergo the guided bone regeneration procedure using a commercially available collagen membrane</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Regenecure AMCA GBR Dental Membrane</intervention_name>
    <description>Patients will undergo Guided Bone Regeneration (GBR) procedure using the Regenecure AMCA GBR Membrane</description>
    <arm_group_label>Regenecure AMCA GBR Dental membrane</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Geistlich Bio-Gide® collagen membrane</intervention_name>
    <description>The Geistlich Bio-Gide® collagen membrane, a commercially available product, will be used in 10 patients.</description>
    <arm_group_label>Collagen membrane</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject must have voluntarily signed the informed consent form before any study
             related action

          -  Age: 18 to 65 with missing teeth, seeking for implant therapy.

          -  Men/Women

          -  In good systemic health

          -  Present with no contra indication against oral surgical interventions

          -  Single/ multiple tooth gap - have at least one missing tooth in the mandible or
             maxilla, requiring one or more dental implants.

          -  The tooth at the implant site(s) must have been extracted or lost at least 6 weeks
             before the date of implantation.

          -  Bone defect(s) must be present with a lateral dimension greater than or equal to 5 mm
             or less.

          -  Full mouth plaque score (FMPI) lower or equal than 25%

          -  Patients must be committed to the study

        Exclusion Criteria:

          -  Medical conditions requiring prolonged use of steroids

          -  Use of Bisphosphonate intravenously

          -  Current pregnancy or breastfeeding women

          -  Alcoholism or chronically drug abuse

          -  Immunocompromised patients

          -  Uncontrolled Diabetes

          -  Conditions or circumstances, in the opinion of the investigator, which would prevent
             completion of study participation or interfere with analysis of study results, such as
             history of non-compliance, or unreliability.

          -  Untreated inflammation

          -  Mucosal diseases or oral lesions

          -  History of local irradiation therapy

          -  Persistent intraoral infection

          -  Patients with bad oral hygiene or unmotivated for normal home care.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lior Shapira, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Haddasah Medical Center, Jerusalem Israel</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Michal Limor, MD</last_name>
    <phone>+ 972-2-5401013</phone>
    <email>michal@regenecure.co.il</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Periodontology Hadassah and Hebrew University Medical Center</name>
      <address>
        <city>Jerusalem</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>August 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 26, 2012</study_first_submitted>
  <study_first_submitted_qc>July 29, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 1, 2012</study_first_posted>
  <last_update_submitted>August 26, 2013</last_update_submitted>
  <last_update_submitted_qc>August 26, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 27, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Guided Tissue Regeneration</keyword>
  <keyword>Dental Implants</keyword>
  <keyword>Membrane, Synthetic</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mouth, Edentulous</mesh_term>
    <mesh_term>Jaw, Edentulous</mesh_term>
    <mesh_term>Jaw, Edentulous, Partially</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

